Viridian Therapeutics Inc (VRDN) - Financial and Strategic SWOT Analysis Review

November 2021 | 49 pages | ID: MA85D745ABAEN
GlobalData

Abstracts

Viridian Therapeutics Inc (VRDN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Viridian Therapeutics Inc (Viridian), formerly Miragen Therapeutics Inc is a clinical stage biopharmaceutical company. The company discovers and develops novel RNA-based therapeutics, with a core focus on microRNAs and their roles in diseases. It focuses on hematological malignancies, neuro-degeneration, fibrosis and cardiovascular disease areas. Viridian lead pipeline products candidates include Cobomarsen (MRG-106), an inhibitor of microRNA-155 for treating blood cancers; Remlarsen (MRG-201), a replacement for miR-29 for treating or preventing pathologic fibrosis and MRG-110, an inhibitor of microRNA-92 for treating ischemic conditions. Viridian is headquartered in Boulder, Colorado, the US.

Viridian Therapeutics Inc Key Recent Developments

Nov 04,2021: Viridian Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate Updates
Aug 11,2021: Viridian Therapeutics Reports Second Quarter 2021 Financial Results and Provides Corporate Updates
Jul 26,2021: Viridian Therapeutics Appoints Kristian Humer as Chief Financial Officer and Chief Business Officer
Jul 15,2021: Viridian Therapeutics appoints Jennifer Moses, CPA to the board of directors and as chair of the audit committee
May 17,2021: VIRIDIAN THERAPEUTICS: Departure of directors or principal officers; election of directors; appointment of principal officers

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Viridian Therapeutics Inc - Key Facts
Viridian Therapeutics Inc - Key Employees
Viridian Therapeutics Inc - Key Employee Biographies
Viridian Therapeutics Inc - Major Products and Services
Viridian Therapeutics Inc - History
Viridian Therapeutics Inc - Company Statement
Viridian Therapeutics Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Viridian Therapeutics Inc - Business Description
R&D Overview
Viridian Therapeutics Inc - Corporate Strategy
Viridian Therapeutics Inc - SWOT Analysis
SWOT Analysis - Overview
Viridian Therapeutics Inc - Strengths
Viridian Therapeutics Inc - Weaknesses
Viridian Therapeutics Inc - Opportunities
Viridian Therapeutics Inc - Threats
Viridian Therapeutics Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Viridian Therapeutics Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
Viridian Therapeutics Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
Viridian Therapeutics Inc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Nov 04, 2021: Viridian Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate Updates
Aug 11, 2021: Viridian Therapeutics Reports Second Quarter 2021 Financial Results and Provides Corporate Updates
Jul 26, 2021: Viridian Therapeutics Appoints Kristian Humer as Chief Financial Officer and Chief Business Officer
Jul 15, 2021: Viridian Therapeutics appoints Jennifer Moses, CPA to the board of directors and as chair of the audit committee
May 17, 2021: VIRIDIAN THERAPEUTICS: Departure of directors or principal officers; election of directors; appointment of principal officers
May 06, 2021: Viridian Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Updates
Mar 25, 2021: Viridian Therapeutics Reports 2020 Financial Results and Provides Corporate Updates
Mar 09, 2021: Viridian Therapeutics To Host Conference Call Discussing Fourth Quarter And Full Year 2020 Results And Corporate Update
Feb 22, 2021: Viridian Therapeutics to Present at Three Upcoming Investor Conferences
Jan 20, 2021: Viridian Therapeutics announces board change

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Viridian Therapeutics Inc, Key Facts
Viridian Therapeutics Inc, Key Employees
Viridian Therapeutics Inc, Key Employee Biographies
Viridian Therapeutics Inc, Major Products and Services
Viridian Therapeutics Inc, History
Viridian Therapeutics Inc, Subsidiaries
Viridian Therapeutics Inc, Key Competitors
Viridian Therapeutics Inc, Ratios based on current share price
Viridian Therapeutics Inc, Annual Ratios
Viridian Therapeutics Inc, Annual Ratios (Cont...1)
Viridian Therapeutics Inc, Interim Ratios
Viridian Therapeutics Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
Viridian Therapeutics Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
Viridian Therapeutics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Viridian Therapeutics Inc, Performance Chart (2016 - 2020)
Viridian Therapeutics Inc, Ratio Charts
Viridian Therapeutics Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
Viridian Therapeutics Inc, Medical Equipment, Deals by Type, 2015 to YTD 2021